GSA Capital Partners’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,153
| Closed | -$8K | – | 1779 |
|
|
2025
Q1 | $8K | Sell |
10,153
-112,869
| -92% | -$88.9K | ﹤0.01% | 1594 |
|
|
2024
Q4 | $170K | Buy |
+123,022
| New | +$170K | 0.01% | 1452 |
|
|
2024
Q1 | – | Sell |
-23,950
| Closed | -$80K | – | 1649 |
|
|
2023
Q4 | $80K | Sell |
23,950
-72,703
| -75% | -$243K | 0.01% | 1406 |
|
|
2023
Q3 | $361K | Sell |
96,653
-24,726
| -20% | -$92.4K | 0.03% | 977 |
|
|
2023
Q2 | $518K | Buy |
121,379
+55,702
| +85% | +$238K | 0.05% | 709 |
|
|
2023
Q1 | $449K | Sell |
65,677
-11,362
| -15% | -$77.7K | 0.04% | 783 |
|
|
2022
Q4 | $610K | Buy |
+77,039
| New | +$610K | 0.08% | 477 |
|
|
2022
Q1 | – | Sell |
-17,781
| Closed | -$284K | – | 1459 |
|
|
2021
Q4 | $284K | Buy |
+17,781
| New | +$284K | 0.04% | 970 |
|
|
2021
Q3 | – | Sell |
-12,453
| Closed | -$172K | – | 1470 |
|
|
2021
Q2 | $172K | Buy |
+12,453
| New | +$172K | 0.02% | 1206 |
|
|
2020
Q1 | – | Sell |
-42,933
| Closed | -$773K | – | 1110 |
|
|
2019
Q4 | $773K | Buy |
42,933
+29,122
| +211% | +$524K | 0.09% | 355 |
|
|
2019
Q3 | $280K | Buy |
+13,811
| New | +$280K | 0.04% | 951 |
|